Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# ![PharmaEssentia Corporation Graphic](https://lunarcrush.com/gi/w:26/t:$6446tw.png) PharmaEssentia Corporation

PharmaEssentia is hiring across multiple departments, with positive sentiment around patient events and partnerships. New FDA Form XXX posted, indicating potential regulatory scrutiny.

### About PharmaEssentia Corporation
PharmaEssentia Corporation is a biopharmaceutical company.  

### Insights [#](/topic/$6446tw/insights)
- PharmaEssentia Corporation creators is up XXXXX% from the previous week.
- PharmaEssentia Corporation engagements is up XXXXX% from the previous week.
- PharmaEssentia Corporation mentions is up XXXXX% from the previous week.

### Price: $ [#](/topic/$6446tw/close)
---
![Price Line Chart](https://lunarcrush.com/gi/w:600/t:$6446tw/c:line/m:close.svg)  
[Price 24-Hour Chart Data](/topic/$6446tw/time-series/close.tsv)  
The price appears stable, likely due to positive Phase X data and anticipation for EHA 2025 presentations, despite the recent FDA Form XXX.  

**1-Year High**: $XXX on 2025-02-17  
**1-Year Low**: $XXXXXX on 2025-04-09  
  
  
### AltRank: undefined [#](/topic/$6446tw/alt_rank)
---
![AltRank Line Chart](https://lunarcrush.com/gi/w:600/t:$6446tw/c:line/m:alt_rank.svg)  
[AltRank 24-Hour Chart Data](/topic/$6446tw/time-series/alt_rank.tsv)  
PharmaEssentia Corporation is currently AltRank #undefined based on combined combined social and market metrics
**Daily Average**: XXXXX  
**1-Year High**: XXXXX on 2025-01-21  
**1-Year Low**: XX on 2025-03-13  
  
  
### Galaxy Score: XX [#](/topic/$6446tw/galaxy_score)
---
![Galaxy Score Line Chart](https://lunarcrush.com/gi/w:600/t:$6446tw/c:line/m:galaxy_score.svg)  
[Galaxy Score 24-Hour Chart Data](/topic/$6446tw/time-series/galaxy_score.tsv)  
**Current Value**: XX  
**Daily Average**: XX  
**1-Year High**: XX on 2025-06-25  
**1-Year Low**: XX on 2025-02-08  
  
  
### Engagements: XX [#](/topic/$6446tw/interactions)
---
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/t:$6446tw/c:line/m:interactions.svg)  
[Engagements 24-Hour Chart Data](/topic/$6446tw/time-series/interactions.tsv)  
**Current Value**: XX  
**Daily Average**: XX  
**1 Week**: XXX +24%  
**1 Month**: XXXXX -XX%  
**6 Months**: XXXXXX +58%  
**1 Year**: XXXXXX +87%  
**1-Year High**: XXX on 2024-12-08  
**1-Year Low**: X on 2024-12-22  

| Social Network | X  | YouTube |
| -------------- | -  | ------- |
| Engagements    | XX | X       |
  

  
  
### Mentions: X [#](/topic/$6446tw/posts_active)
---
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/t:$6446tw/c:line/m:posts_active.svg)  
[Mentions 24-Hour Chart Data](/topic/$6446tw/time-series/posts_active.tsv)  
**Current Value**: X  
**Daily Average**: X  
**1 Week**: XX +12%  
**1 Month**: XX -XXXX%  
**6 Months**: XXX +110%  
**1 Year**: XXX +279%  
**1-Year High**: XX on 2025-05-08  
**1-Year Low**: X on 2024-07-27  

| Social Network | X  | YouTube |
| -------------- | -  | ------- |
| Mentions       | XX | X       |
  

  
  
### Creators: X [#](/topic/$6446tw/contributors_active)
---
![Creators Line Chart](https://lunarcrush.com/gi/w:600/t:$6446tw/c:line/m:contributors_active.svg)  
[Creators 24-Hour Chart Data](/topic/$6446tw/time-series/contributors_active.tsv)  
X unique social accounts have posts mentioning PharmaEssentia Corporation in the last XX hours which is no change from in the previous XX hours
**Daily Average**: X  
**1 Week**: X +14%  
**1 Month**: X -XX%  
**6 Months**: XX +50%  
**1 Year**: XX +167%  
**1-Year High**: X on 2025-06-10  
**1-Year Low**: X on 2024-07-27  
  
  
### Sentiment: XX% [#](/topic/$6446tw/sentiment)
---
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:$6446tw/c:line/m:sentiment.svg)  
[Sentiment 24-Hour Chart Data](/topic/$6446tw/time-series/sentiment.tsv)  
**Current Value**: XX%  
**Daily Average**: XX%  
**1 Week**: XX% -XX%  
**1 Month**: XX% -XX%  
**6 Months**: XX% -XX%  
**1 Year**: XX% -XX%  
**1-Year High**: XXX% on 2024-12-01  
**1-Year Low**: XX% on 2025-05-20  

**Most Supportive Themes**
- **Positive Developments:** (90%) Positive sentiment around patient events, partnerships, and Phase X data.
- **Strategic Growth:** (9%) Company growth pillars and innovative therapies are being discussed.
  
**Most Critical Themes**
- **Regulatory Scrutiny:** (0.01%)  Regulatory scrutiny indicated by a new FDA Form XXX.
  
Network engagement breakdown:  
| Network | Positive | %   | Neutral | %   | Negative | %  |
| ------- | -------- | -   | ------- | -   | -------- | -  |
| X       | XX       | XX% | XX      | XX% | X        | X% |
| YouTube | X        | X%  | X       | XX% | X        | X% |
|         |          |     |         |     |          |    |
| Total   | XX       | XX% | XX      | XX% | X        | X% |
  

  
  
### Market Cap: $undefined [#](/topic/$6446tw/market_cap)
---
![Market Cap Line Chart](https://lunarcrush.com/gi/w:600/t:$6446tw/c:line/m:market_cap.svg)  
[Market Cap 24-Hour Chart Data](/topic/$6446tw/time-series/market_cap.tsv)  
**Current Value**: $undefined  
**Daily Average**: $XXXXXXXXXXXXXXX  
**1-Year High**: $XXXXXXXXXXXXXXX on 2025-02-17  
**1-Year Low**: $XXXXXXXXXXXXXXX on 2025-03-31  

**Top assets mentioned**
In the posts about PharmaEssentia Corporation in the last XX hours

[Merck & Co., Inc. (MRK)](/topic/$mrk)
[Innovative Solutions & Support (ISSC)](/topic/$issc)
[Novartis AG (NVS)](/topic/novartis)

**Top topics mentioned**
In the posts about PharmaEssentia Corporation in the last XX hours

[vera](/topic/vera), [positions](/topic/positions), [stocks healthcare](/topic/stocks-healthcare), [supported](/topic/supported), [bose](/topic/bose), [if you](/topic/if-you), [taiwan](/topic/taiwan), [$mrk](/topic/$mrk), [pi](/topic/pi), [approved](/topic/approved), [$issc](/topic/$issc), [mesa](/topic/mesa), [novartis](/topic/novartis), [$novnsw](/topic/$novnsw), [superior](/topic/superior), [stocks](/topic/stocks)

### Top Social Posts [#](/topic/$6446tw/posts)
---
Top posts by engagements in the last XX hours

*Showing only X posts for non-authenticated requests. Use your API key in requests for full results.*

"For Buzz advocating for his own health and finding a specialist he could partner with were critical steps following his polycythemia vera diagnosis. Hear Buzz tell the story of his PV journey. Listen to more PV patient stories:"  
[@PharmaEssentia](/creator/x/PharmaEssentia) on [X](/post/tweet/1948812787154636849) 2025-07-25 18:29:10 UTC XXX followers, XX engagements


"During BIO AsiaTaiwan 2025 GeneOnline visited PharmaEssentia a global biopharmaceutical company known for developing innovative therapies for hematologic malignancies cancers and immune-related diseases. The company outlined its four strategic pillars for growth: 1) Ropeginterferon alfa-2b (BESREMi) a long-acting mono-pegylated interferon already approved for polycythemia vera in the U.S. EU and Asia 2) a growing immune-oncology pipeline featuring anti-TIM-3 and anti-PD-1 checkpoint inhibitors 3) its proprietary PEGylation platform for creating long-acting biologics Stay informed throughout"  
[@GeneOnlineNews](/creator/x/GeneOnlineNews) on [X](/post/tweet/1948338551248310716) 2025-07-24 11:04:43 UTC 4754 followers, XX engagements


"Looking for a new role Join our team at PharmaEssentia where science and purpose come together to drive patient impact. Were hiring across multiple departments including Commercial R&D Medical BD and more. Explore open positions:"  
[@PharmaEssentia](/creator/x/PharmaEssentia) on [X](/post/tweet/1947650413999587666) 2025-07-22 13:30:18 UTC XXX followers, XX engagements

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

PharmaEssentia Corporation Graphic PharmaEssentia Corporation

PharmaEssentia is hiring across multiple departments, with positive sentiment around patient events and partnerships. New FDA Form XXX posted, indicating potential regulatory scrutiny.

About PharmaEssentia Corporation

PharmaEssentia Corporation is a biopharmaceutical company.

Insights #

  • PharmaEssentia Corporation creators is up XXXXX% from the previous week.
  • PharmaEssentia Corporation engagements is up XXXXX% from the previous week.
  • PharmaEssentia Corporation mentions is up XXXXX% from the previous week.

Price: $ #


Price Line Chart
Price 24-Hour Chart Data
The price appears stable, likely due to positive Phase X data and anticipation for EHA 2025 presentations, despite the recent FDA Form XXX.

1-Year High: $XXX on 2025-02-17
1-Year Low: $XXXXXX on 2025-04-09

AltRank: undefined #


AltRank Line Chart
AltRank 24-Hour Chart Data
PharmaEssentia Corporation is currently AltRank #undefined based on combined combined social and market metrics Daily Average: XXXXX
1-Year High: XXXXX on 2025-01-21
1-Year Low: XX on 2025-03-13

Galaxy Score: XX #


Galaxy Score Line Chart
Galaxy Score 24-Hour Chart Data
Current Value: XX
Daily Average: XX
1-Year High: XX on 2025-06-25
1-Year Low: XX on 2025-02-08

Engagements: XX #


Engagements Line Chart
Engagements 24-Hour Chart Data
Current Value: XX
Daily Average: XX
1 Week: XXX +24%
1 Month: XXXXX -XX%
6 Months: XXXXXX +58%
1 Year: XXXXXX +87%
1-Year High: XXX on 2024-12-08
1-Year Low: X on 2024-12-22

Social Network X YouTube
Engagements XX X

Mentions: X #


Mentions Line Chart
Mentions 24-Hour Chart Data
Current Value: X
Daily Average: X
1 Week: XX +12%
1 Month: XX -XXXX%
6 Months: XXX +110%
1 Year: XXX +279%
1-Year High: XX on 2025-05-08
1-Year Low: X on 2024-07-27

Social Network X YouTube
Mentions XX X

Creators: X #


Creators Line Chart
Creators 24-Hour Chart Data
X unique social accounts have posts mentioning PharmaEssentia Corporation in the last XX hours which is no change from in the previous XX hours Daily Average: X
1 Week: X +14%
1 Month: X -XX%
6 Months: XX +50%
1 Year: XX +167%
1-Year High: X on 2025-06-10
1-Year Low: X on 2024-07-27

Sentiment: XX% #


Sentiment Line Chart
Sentiment 24-Hour Chart Data
Current Value: XX%
Daily Average: XX%
1 Week: XX% -XX%
1 Month: XX% -XX%
6 Months: XX% -XX%
1 Year: XX% -XX%
1-Year High: XXX% on 2024-12-01
1-Year Low: XX% on 2025-05-20

Most Supportive Themes

  • Positive Developments: (90%) Positive sentiment around patient events, partnerships, and Phase X data.
  • Strategic Growth: (9%) Company growth pillars and innovative therapies are being discussed.

Most Critical Themes

  • Regulatory Scrutiny: (0.01%) Regulatory scrutiny indicated by a new FDA Form XXX.

Network engagement breakdown:

Network Positive % Neutral % Negative %
X XX XX% XX XX% X X%
YouTube X X% X XX% X X%
Total XX XX% XX XX% X X%

Market Cap: $undefined #


Market Cap Line Chart
Market Cap 24-Hour Chart Data
Current Value: $undefined
Daily Average: $XXXXXXXXXXXXXXX
1-Year High: $XXXXXXXXXXXXXXX on 2025-02-17
1-Year Low: $XXXXXXXXXXXXXXX on 2025-03-31

Top assets mentioned In the posts about PharmaEssentia Corporation in the last XX hours

Merck & Co., Inc. (MRK) Innovative Solutions & Support (ISSC) Novartis AG (NVS)

Top topics mentioned In the posts about PharmaEssentia Corporation in the last XX hours

vera, positions, stocks healthcare, supported, bose, if you, taiwan, $mrk, pi, approved, $issc, mesa, novartis, $novnsw, superior, stocks

Top Social Posts #


Top posts by engagements in the last XX hours

Showing only X posts for non-authenticated requests. Use your API key in requests for full results.

"For Buzz advocating for his own health and finding a specialist he could partner with were critical steps following his polycythemia vera diagnosis. Hear Buzz tell the story of his PV journey. Listen to more PV patient stories:"
@PharmaEssentia on X 2025-07-25 18:29:10 UTC XXX followers, XX engagements

"During BIO AsiaTaiwan 2025 GeneOnline visited PharmaEssentia a global biopharmaceutical company known for developing innovative therapies for hematologic malignancies cancers and immune-related diseases. The company outlined its four strategic pillars for growth: 1) Ropeginterferon alfa-2b (BESREMi) a long-acting mono-pegylated interferon already approved for polycythemia vera in the U.S. EU and Asia 2) a growing immune-oncology pipeline featuring anti-TIM-3 and anti-PD-1 checkpoint inhibitors 3) its proprietary PEGylation platform for creating long-acting biologics Stay informed throughout"
@GeneOnlineNews on X 2025-07-24 11:04:43 UTC 4754 followers, XX engagements

"Looking for a new role Join our team at PharmaEssentia where science and purpose come together to drive patient impact. Were hiring across multiple departments including Commercial R&D Medical BD and more. Explore open positions:"
@PharmaEssentia on X 2025-07-22 13:30:18 UTC XXX followers, XX engagements

PharmaEssentia Corporation
/topic/$6446tw